[Osteoporosis without fracture: when do we treat?].
Osteoporosis without prevalent fracture is defined by a low bone mineral density (BMD), which is a risk factor for fracture. We also use the FRAX tool to determine treatment indications. The objective of the treatment is to reduce fracture risk--which has been defined by BMD and clinical risk factors--with various types of therapeutic classes, such as bisphosphonates, strontium ranelate, denosumab and raloxifene. Calcium and vitamin D may be a useful addition.